Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

about

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Item

http://www.wikidata.org/entity/Q54977188

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@en

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@nl

type

Item

label

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@en

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@nl

prefLabel

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@en

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

@nl

P1476

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

@en

P2093

Anabelle Brocard

http://www.w3.org/2001/XMLSchema#string

Christelle Volteau

http://www.w3.org/2001/XMLSchema#string

Christophe Bedane

http://www.w3.org/2001/XMLSchema#string

Gaëlle Quéreux

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Nguyen

http://www.w3.org/2001/XMLSchema#string

Lucie Peuvrel

http://www.w3.org/2001/XMLSchema#string

Mélanie Saint-Jean

http://www.w3.org/2001/XMLSchema#string

Nicole Basset-Seguin

http://www.w3.org/2001/XMLSchema#string

Soraya Saiagh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Nivolumab in previously untreated melanoma without BRAF mutation

Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells.

Adoptive cell transfer as personalized immunotherapy for human cancer.

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.

Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

P304

3530148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/3530148

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Brigitte Dréno

Anne-Chantal Knol

Marie-Christine Pandolfino

Amir Khammari

P577

2018-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29750176

http://www.w3.org/2001/XMLSchema#string

P932

5883986

http://www.w3.org/2001/XMLSchema#string